Back to search
Henoch-Schoenlein Purpura Nephritis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Henoch-Schoenlein Purpura Nephritis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Henoch-Schoenlein Purpura Nephritis trials you may qualify forThe primary objectives of this study are to characterize ravulizumab pharmacokinetics (PK) and pharmacodynamics (PD), and to evaluate safety and efficacy follow…
The purpose of this study is to evaluate the safety and tolerability of atacicept in adult and adolescent participants and to measure the effect in reducing pro…
To evaluate the safety, efficacy and tolerability of sparsentan oral suspension and tablets, and assess changes in proteinuria after once-daily dosing over 108…
Global Burden of Diseases ranks chronic kidney disease (CKD) as the 12th leading cause of death, with an estimated 20% increase from 2010 to 2019. India is the…
To further evaluate the efficacy and safety of Telitacicept in the treatment of pediatric IgA vasculitis nephritis (IgAVN) within real-world settings, this stud…
This clinical trial is a prospective, multicenter, non-randomized controlled study designed to evaluate the efficacy and safety of Telitacicept, a novel biologi…